AGL 40.00 Decreased By ▼ -0.16 (-0.4%)
AIRLINK 129.53 Decreased By ▼ -2.20 (-1.67%)
BOP 6.68 Decreased By ▼ -0.01 (-0.15%)
CNERGY 4.63 Increased By ▲ 0.16 (3.58%)
DCL 8.94 Increased By ▲ 0.12 (1.36%)
DFML 41.69 Increased By ▲ 1.08 (2.66%)
DGKC 83.77 Decreased By ▼ -0.31 (-0.37%)
FCCL 32.77 Increased By ▲ 0.43 (1.33%)
FFBL 75.47 Increased By ▲ 6.86 (10%)
FFL 11.47 Increased By ▲ 0.12 (1.06%)
HUBC 110.55 Decreased By ▼ -1.21 (-1.08%)
HUMNL 14.56 Increased By ▲ 0.25 (1.75%)
KEL 5.39 Increased By ▲ 0.17 (3.26%)
KOSM 8.40 Decreased By ▼ -0.58 (-6.46%)
MLCF 39.79 Increased By ▲ 0.36 (0.91%)
NBP 60.29 No Change ▼ 0.00 (0%)
OGDC 199.66 Increased By ▲ 4.72 (2.42%)
PAEL 26.65 Decreased By ▼ -0.04 (-0.15%)
PIBTL 7.66 Increased By ▲ 0.18 (2.41%)
PPL 157.92 Increased By ▲ 2.15 (1.38%)
PRL 26.73 Increased By ▲ 0.05 (0.19%)
PTC 18.46 Increased By ▲ 0.16 (0.87%)
SEARL 82.44 Decreased By ▼ -0.58 (-0.7%)
TELE 8.31 Increased By ▲ 0.08 (0.97%)
TOMCL 34.51 Decreased By ▼ -0.04 (-0.12%)
TPLP 9.06 Increased By ▲ 0.25 (2.84%)
TREET 17.47 Increased By ▲ 0.77 (4.61%)
TRG 61.32 Decreased By ▼ -1.13 (-1.81%)
UNITY 27.43 Decreased By ▼ -0.01 (-0.04%)
WTL 1.38 Increased By ▲ 0.10 (7.81%)
BR100 10,407 Increased By 220 (2.16%)
BR30 31,713 Increased By 377.1 (1.2%)
KSE100 97,328 Increased By 1781.9 (1.86%)
KSE30 30,192 Increased By 614.4 (2.08%)
World

South Korea reviews AstraZeneca vaccine for elderly under rollout plan

  • Health authorities will expand vaccinations towards the second half of the year with an aim to reach herd immunity by November.
  • Inoculations would begin in February starting with key groups, including medical workers in the front line of coronavirus treatment.
Published January 28, 2021

SEOUL: South Korea said on Thursday it would begin COVID-19 vaccinations for the general public in the third quarter but review the use of AstraZeneca's vaccine to the elderly because of limited efficacy data overseas.

Health authorities will expand vaccinations towards the second half of the year with an aim to reach herd immunity by November, Korea Disease Control and Prevention Agency (KDCA) director Jeong Eun-kyeong told a news briefing.

Inoculations would begin in February starting with key groups, including medical workers in the front line of coronavirus treatment, the elderly and staff in nursing homes, Jeong said.

AstraZeneca denied media reports this week that its vaccine is not very effective for people over 65, saying a strong immune response to the vaccine had been shown in blood analysis of elderly trial participants.

South Korea has secured 106 million doses to allow for coverage of 56 million people, more than the 52 million residents of the country.

It has deals with four drugmakers - AstraZeneca, Pfizer Inc , Johnson & Johnson's Janssen, Moderna Inc and the World Health Organization-backed global COVAX scheme.

The KDCA reported 497 new COVID-19 cases as of Wednesday. The total number of infections reported in the country now stands at 76,926, with the death toll of 1,386.

Nearly half of infections in South Korea over the past year were caused by cluster infections emerging from specific close-knit groups, including religious facilities and nursing homes.

Comments

Comments are closed.